These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PSA
110 results:

  • 1. A systematic review of Selenium as a complementary treatment in cancer patients.
    Krannich F; Mücke R; Büntzel J; Schomburg L; Micke O; Hübner J; Dörfler J
    Complement Ther Med; 2024 Nov; 86():103095. PubMed ID: 39374898
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Asciminib for third-line treatment of chronic myeloid leukemia: Cost-effectiveness analysis based on treatment-free remission approach.
    García Molina A
    Farm Hosp; 2024; 48(5):T222-T229. PubMed ID: 39013681
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Asciminib for third-line treatment of chronic myeloid leukemia: Cost-effectiveness analysis based on treatment-free remission approach.
    Garcia Molina A
    Farm Hosp; 2024; 48(5):222-229. PubMed ID: 38679535
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides.
    Assirelli E; Ciaffi J; Scorcu V; Naldi S; Brusi V; Mancarella L; Lisi L; Pignatti F; Ursini F; Neri S
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542097
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison.
    Beelen DW; Iacobelli S; Koster L; Eikema DJ; van Biezen A; Stölzel F; Ciceri F; Bethge W; Dreger P; Wagner-Drouet EM; Reményi P; Stelljes M; Markiewicz M; McLornan DP; Yakoub-Agha I; Mohty M
    Bone Marrow Transplant; 2024 May; 59(5):670-679. PubMed ID: 38383713
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
    Pencik J; Philippe C; Schlederer M; Atas E; Pecoraro M; Grund-Gröschke S; Li WJ; Tracz A; Heidegger I; Lagger S; Trachtová K; Oberhuber M; Heitzer E; Aksoy O; Neubauer HA; Wingelhofer B; Orlova A; Witzeneder N; Dillinger T; Redl E; Greiner G; D'Andrea D; Östman JR; Tangermann S; Hermanova I; Schäfer G; Sternberg F; Pohl EE; Sternberg C; Varady A; Horvath J; Stoiber D; Malcolm TI; Turner SD; Parkes EE; Hantusch B; Egger G; Rose-John S; Poli V; Jain S; Armstrong CWD; Hoermann G; Goffin V; Aberger F; Moriggl R; Carracedo A; McKinney C; Kennedy RD; Klocker H; Speicher MR; Tang DG; Moazzami AA; Heery DM; Hacker M; Kenner L
    Mol Cancer; 2023 Aug; 22(1):133. PubMed ID: 37573301
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.
    Stangl-Kremser J; Sun M; Ho B; Thomas J; Nauseef JT; Osborne JR; Molina A; Sternberg CN; Nanus DM; Bander NH; Tagawa S
    Prostate; 2023 Oct; 83(14):1351-1357. PubMed ID: 37424145
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mycobacterial Spindle Cell Pseudotumor of the Nasal Cavity.
    Argyris PP; Wakely PE
    Head Neck Pathol; 2023 Sep; 17(3):782-787. PubMed ID: 37027086
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic Value of Magnetic Resonance Susceptibility-Weighted Imaging Scanning in Different Types of Early Prostate Cancer.
    Gao R; Liu J; Zhu H
    Scanning; 2022; 2022():4884646. PubMed ID: 35795617
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic leukemia in the United States.
    Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
    Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective.
    Pratz KW; Chai X; Xie J; Yin L; Nie X; Montez M; Iantuono E; Downs L; Ma E
    Pharmacoeconomics; 2022 Aug; 40(8):777-790. PubMed ID: 35696071
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Penile secondary lesions: a rare entity detected by PET/CT.
    Davidson T; Domachevsky L; Giladi Y; Fridman E; Dotan Z; Rosenzweig B; Leibowitz R; Ben Shimol J
    Sci Rep; 2021 Mar; 11(1):5912. PubMed ID: 33723317
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
    Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
    Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Ye B; Zhou Y; Liu Y; Li X; Li T; Qi X
    Anticancer Agents Med Chem; 2021; 21(7):919-926. PubMed ID: 32698748
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intestinal microbes influence development of thymic lymphocytes in early life.
    Ennamorati M; Vasudevan C; Clerkin K; Halvorsen S; Verma S; Ibrahim S; Prosper S; Porter C; Yeliseyev V; Kim M; Gardecki J; Sassi S; Tearney G; Cherayil BJ; Bry L; Seed B; Jain N
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2570-2578. PubMed ID: 31964813
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
    Ciurea SO; Kongtim P; Varma A; Rondon G; Chen J; Srour S; Bashir Q; Alousi A; Mehta R; Oran B; Popat U; Hosing C; Olson A; Daver N; Konopleva M; Champlin RE
    Blood; 2020 Feb; 135(6):449-452. PubMed ID: 31826244
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Glucoside Derivatives Of Podophyllotoxin: Synthesis, Physicochemical Properties, And Cytotoxicity.
    Zi CT; Yang L; Kong QH; Li HM; Yang XZ; Ding ZT; Jiang ZH; Hu JM; Zhou J
    Drug Des Devel Ther; 2019; 13():3683-3692. PubMed ID: 31695335
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
    Rambaldi A; Ribera JM; Kantarjian HM; Dombret H; Ottmann OG; Stein AS; Tuglus CA; Zhao X; Kim C; Martinelli G
    Cancer; 2020 Jan; 126(2):304-310. PubMed ID: 31626339
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A rare case of non-traumatic intrasplenic pseudoaneurysms in a patient with acute T-cell lymphoblastic leukemia.
    Trinci M; Giangregorio C; Calabrese G; Ottaviani P; Riu P; Galluzzo M; Miele V
    J Ultrasound; 2021 Mar; 24(1):85-90. PubMed ID: 31372947
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Incidental Finding of Acute Lymphocytic leukemia in a Prostate-Specific Membrane Antigen PET/CT.
    Acksteiner C; Sounness B
    Clin Nucl Med; 2019 Sep; 44(9):e529-e531. PubMed ID: 31306192
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 6.